Vector is Children's Hospital Boston's blog about research and innovation in pediatric and adult medicine. We report and comment on medical innovations and advances – from bench to bedside – touching on scientific, business and policy issues. Our ranks include science writers, physicians, lab researchers, market analysts and others inside and outside the hospital.
Ninety percent of lung cancer deaths are caused by the tumor's spread – or metastasis – to other organs. Researchers have now discovered an approach to blocking metastasis in the most common type of lung cancer, adenocarcinoma, that potentially could be added to chemotherapy treatments aimed at shrinking the primary tumor.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1sMFPlR
Cap comentari:
Publica un comentari a l'entrada